E

EQL Pharma
EQL

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
SEK1.79B
EV
SEK2.19B
Shares Outstanding
29.53M
Beta
0.54
Industry
-

Wall Street View

Analyst Rating
NO_OPINION
Analyst Target Price
Number of Analysts
1
P/E 2026E
32.46x
P/Revenue 2026E
3.76x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About EQL Pharma AB (publ)

gainify

E

EQL Pharma AB (publ)

EQL

EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers injection products for inpatient care and formulations for outpatient care. EQL...

Sector

Industry

CEO

Schorling, Axel

Employees

20

IPO Date

Headquarters

Stortorget 1, 3rd Floor, Lund, Skåne County, 222 23, Sweden

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.